Novacyt S.A. (EPA:ALNOV)
0.4105
+0.0010 (0.24%)
Jul 14, 2026, 9:02 AM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €29.67 million as of July 13, 2026. Its market cap has decreased by -14.39% in one year.
Market Cap
29.67M
Enterprise Value
19.57M
Revenue
22.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.41
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 29.67M, an increase of 25.97%. That is a compound annual growth rate of 1.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 29.67M | 7.63% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 213.45M |
| Median Technologies | 176.51M |
| Guerbet | 114.80M |
| Theraclion | 49.06M |
| Mauna Kea Technologies | 32.01M |
| Diagnostic Medical Systems | 31.10M |
| Implanet | 24.74M |
| Ikonisys | 23.76M |